tert-Butyl 5-cyano-1H-pyrrolo[3,2-b]pyridine-1-carboxylate
96%
- Product Code: 121687
CAS:
1364663-38-6
| Molecular Weight: | 243.26 g./mol | Molecular Formula: | C₁₃H₁₃N₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD21648255 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a cyano group and a pyrrolopyridine core, makes it valuable for constructing complex compounds targeting specific therapeutic areas. It is often employed in the preparation of kinase inhibitors, which are crucial in the treatment of cancers and inflammatory diseases. Additionally, its tert-butyl carboxylate group provides stability and facilitates further chemical modifications, making it a versatile building block in medicinal chemistry. Researchers also explore its potential in designing novel drug candidates for neurological disorders due to its ability to interact with specific receptors in the brain.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | £164.47 |
+
-
|
| 0.250 | 10-20 days | £566.28 |
+
-
|
tert-Butyl 5-cyano-1H-pyrrolo[3,2-b]pyridine-1-carboxylate
This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a cyano group and a pyrrolopyridine core, makes it valuable for constructing complex compounds targeting specific therapeutic areas. It is often employed in the preparation of kinase inhibitors, which are crucial in the treatment of cancers and inflammatory diseases. Additionally, its tert-butyl carboxylate group provides stability and facilitates further chemical modifications, making it a versatile building block in medicinal chemistry. Researchers also explore its potential in designing novel drug candidates for neurological disorders due to its ability to interact with specific receptors in the brain.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :